Myopic Monovision: EDOF vs. Monofocal IOL
Primary Purpose
Cataract
Status
Recruiting
Phase
Not Applicable
Locations
Austria
Study Type
Interventional
Intervention
enhanced depth of focus IOL
monofocal IOL
Sponsored by
About this trial
This is an interventional treatment trial for Cataract focused on measuring Cataract, Myopia, enhanced depth of focus intraocular lens, mini-monovision
Eligibility Criteria
Inclusion Criteria:
- age-related cataract in both eyes
- bilateral cataract surgery
- motivated to be less spectacle dependent in the intermediate to near vision range
- expected CDVA of 0.8 snellen or better
- myopic patients with shorter eye having an axial length of at least 25.5 mm
- age 21 and older
- planned postoperative astigmatis lower than or 0.75 D
- written informed consent prior to recruitment
Exclusion Criteria:
- pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
- retinitis pigmentosa
- chronic uveitis
- amblyopia
- pupil decentration > 0.8 mm, pupil size < 2.8 mm
- preceded retinal surgery
- preceded LASIK
- any ophthalmic abnormality that could compromise visual function or the measurements
Sites / Locations
- Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital ViennaRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Acunex Vario AN6V
Acunex AN6
Arm Description
Patient will receive the enhanced depth of focus IOL during cataract surgery
Patient will receive the monofocal IOL during cataract surgery
Outcomes
Primary Outcome Measures
Spectacle independence
Spectacle independence will be assessed using a questionnaire and compared between patients with EDOF IOLs and patients with the monofocal IOL
Secondary Outcome Measures
Visual acuity
Visual acuity will be assessed using ETDRS charts and will be compared between patients with the EDOF IOLs and patients with the monofocal IOLs
Reading speed
Reading speed will be analysed by using the Salzburg Reading Desk and will be compared between patients with the EDOF IOLs and patients with the monofocal IOLs
Stereo vision
Stereo vision will be analysed by using a 3D-computer program and will be compared between patients with the EDOF IOLs and patients with the monofocal IOLs
Full Information
NCT ID
NCT05194670
First Posted
January 4, 2022
Last Updated
January 4, 2022
Sponsor
Vienna Institute for Research in Ocular Surgery
1. Study Identification
Unique Protocol Identification Number
NCT05194670
Brief Title
Myopic Monovision: EDOF vs. Monofocal IOL
Official Title
Comparison Between Bilateral Extended Depth of Focus (EDOF) Intraocular Lens Myopic Monovision and Monofocal Intraocular Lens Myopic Monovision for Myopic Patients: a Randomised Trial
Study Type
Interventional
2. Study Status
Record Verification Date
January 2022
Overall Recruitment Status
Recruiting
Study Start Date
August 1, 2017 (Actual)
Primary Completion Date
August 1, 2023 (Anticipated)
Study Completion Date
August 1, 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vienna Institute for Research in Ocular Surgery
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Comparison of EDOF IOLs versus monofocal IOLs with mini-monovision concerning intermediate and near visual acuity.
Detailed Description
Spectacle independence is one of the main aims in modern cataract surgery. Although bilateral monofocal IOL implantation, aiming for emmetropia or low myopia, leads to high levels of patient satifsfaction in distance vision, spectacle dependence for reading and other near vision tasks is the usual result.
There are different techniques to reduce spectacle dependence, the most common one is the use of multifocal IOLs. However, a variable number of patients complain of problems, such as glare or haloes. It appears that multifocal IOL technology does lead to less satisfying results in patients with pre-operative myopia. These patients are used to very good near vision when taking off their spectacles. Many of these patients would prefer to keep their distance spectacles and ideally would like to function well at intermediate and near distance without glasses for e.g. reading and computer- or household work.
One option to enhance intermediate vision and to leave patients with good contrast sensitivity is the use of extended depth of focus (EDOF) IOLs. One example is the ACUNEX Vario AN6V with a near add of 1.50 D. In particular, this design provides improved vision at a distance of 66 cm and more. Additional key features of the low-add IOL include good contrast sensitivity for twilight vision, optimized depth of focus, and natural imaging quality and color sensitivity.
Another option to allow spectacle independence is (mini-)monovision. For some people, who are in need of intermediate and near reading vision most of the time, mini-monovision with one eye having intermediate (arms length) and one eye having near (reading) vision is a good option ("myopic monovision").
Hence, the aim of the study is to analyse intermediate and near vision outcomes in myopic patients with either EDOF IOLs or monofocal IOLs with mini-monovision.
124 eyes of 62 patients will be included into this study. According to randomization, 31 patients will receive the EDOF IOLs (Acunex Vario AN6V) bilaterally, whereas in the other 31 patients a monofocal IOL (Acunex AN6) with mini-monovision will be implanted bilaterally. Follow-Up visits will be 1 hour, 1 week, and 2 months after surgery. A slit lamp examination, autorefraction and subjective refraction as well as visual acuity testing, reading performance, stereo vision testing and defocus curve assessment will be performed at this visits.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cataract
Keywords
Cataract, Myopia, enhanced depth of focus intraocular lens, mini-monovision
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
62 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Acunex Vario AN6V
Arm Type
Experimental
Arm Description
Patient will receive the enhanced depth of focus IOL during cataract surgery
Arm Title
Acunex AN6
Arm Type
Experimental
Arm Description
Patient will receive the monofocal IOL during cataract surgery
Intervention Type
Device
Intervention Name(s)
enhanced depth of focus IOL
Intervention Description
Acunex Vario AN6V, enhanced depth of focus IOL
Intervention Type
Device
Intervention Name(s)
monofocal IOL
Intervention Description
Acunex AN6, monofocal IOL
Primary Outcome Measure Information:
Title
Spectacle independence
Description
Spectacle independence will be assessed using a questionnaire and compared between patients with EDOF IOLs and patients with the monofocal IOL
Time Frame
24 months
Secondary Outcome Measure Information:
Title
Visual acuity
Description
Visual acuity will be assessed using ETDRS charts and will be compared between patients with the EDOF IOLs and patients with the monofocal IOLs
Time Frame
24 months
Title
Reading speed
Description
Reading speed will be analysed by using the Salzburg Reading Desk and will be compared between patients with the EDOF IOLs and patients with the monofocal IOLs
Time Frame
24 months
Title
Stereo vision
Description
Stereo vision will be analysed by using a 3D-computer program and will be compared between patients with the EDOF IOLs and patients with the monofocal IOLs
Time Frame
24 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
105 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
age-related cataract in both eyes
bilateral cataract surgery
motivated to be less spectacle dependent in the intermediate to near vision range
expected CDVA of 0.8 snellen or better
myopic patients with shorter eye having an axial length of at least 25.5 mm
age 21 and older
planned postoperative astigmatis lower than or 0.75 D
written informed consent prior to recruitment
Exclusion Criteria:
pregnancy (pregnancy test will be taken pre-operatively in women of reproductive age)
retinitis pigmentosa
chronic uveitis
amblyopia
pupil decentration > 0.8 mm, pupil size < 2.8 mm
preceded retinal surgery
preceded LASIK
any ophthalmic abnormality that could compromise visual function or the measurements
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
John Falasinnu, MD
Phone
01 91021
Ext
57564
Email
office@viros.at
First Name & Middle Initial & Last Name or Official Title & Degree
Oliver Findl, MD
Phone
01 91021
Ext
57564
Email
office@viros.at
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Oliver Findl, MD
Organizational Affiliation
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
Official's Role
Principal Investigator
Facility Information:
Facility Name
Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna
City
Vienna
ZIP/Postal Code
1140
Country
Austria
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
John Falasinnu, MD
Phone
01 91021
Ext
57564
Email
office@viros.at
First Name & Middle Initial & Last Name & Degree
Oliver Findl, MD
Phone
01 91021
Ext
57564
Email
office@viros.at
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Myopic Monovision: EDOF vs. Monofocal IOL
We'll reach out to this number within 24 hrs